SBI Securities’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

SBI Securities’s Portfolio ATXI Stock Details ATXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9	Closed	-$18	–	4232
2024 Q4	$18	Buy	+9	New	+$18	﹤0.01%	3860

SBI Securities's ATXI Position: Q1 2025 in Review

SBI Securities sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q1 2025, closing a stake of 9 shares — an estimated $18 sold.

SBI Securities first reported a position in ATXI in Q4 2024 and held it in 1 quarter. The position peaked at $18 in Q4 2024. 0 funds tracked by Wall St. Rank hold ATXI as of Q1 2025.

SBI Securities reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
SBI Securities sold 9 Avenue Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $18.
SBI Securities first reported a position in Avenue Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
SBI Securities's Avenue Therapeutics, Inc. Common Stock position peaked at $18 in Q4 2024.
0 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.